logo

Preparation and biological evaluation of 99Tcm-labelled fatty acids

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Preparation and biological evaluation of 99Tcm-labelled fatty acids

LIANG Jixin
HU Ji
CHEN Baojun
LUO Lianzhe
LI Hongyu
SHEN Langtao
LUO Zhifu
Nuclear Science and TechniquesVol.18, No.3pp.159-163Published in print 20 Jun 2007
37600

The aim of the present work was to develop radiolabelling fatty acids based on 99Tcm carbonyl chemistry for heart imaging. Undecanoic acids functionalised with iminodiacetatic acid and cysteine were radiolabelled with [99Tcm (CO)3(H2O)3]+ intermediates, and their radiolabelling conditions were carefully studied. Biodistribution of 99Tcm (CO)3-CYST FAC11 and 99Tcm (CO)3-IDA FAC11 were observed in normal mice. The results showed that two 99Tcm-labelled compounds had similar profile in terms of high initial radioactivity uptake and rapid washout of radiotracers in the heart. 99Tcm (CO)3-IDA FAC11 was mainly excreted via hepatobiliary system in contrast to 99Tcm (CO)3-CYST FAC11, which was excreted from urinary system. It may be in part attributed to the more lipophilicity of 99Tcm (CO)3-IDA FAC11 than 99Tcm (CO)3-CYST FAC11.

99Tcm-labellingFatty acid derivativesBiodistribution
References
[1] Liedke A J. Prog Cardiovasc Dis, 1981, 23: 321-336.
[2] Tamaki N, Morita K, Kuge Y, et al. J Nucl Med, 2000, 41: 1525-1534.
[3] Knapp F F, Kropp J. Eur J Nucl Med, 1995, 221: 361-381.
[4] Jones G S, Elmaleh D R, Strauss H W, et al. J Nucl Med Biol, 1994, 21: 117-123.
[5] Magata Y, Kawaguchi T, Ukon M, et al. Bioconjugate Chem, 2004, 15: 389-393.
[6] Alberto R, Ortner K, Wheatley N, et al. J Am Chem Soc, 2001, 123: 3135-3136.
[7] Schibli R, La Bella R, Alberto R, et al. Bioconjug Chem, 2000, 11: 345-351.
[8] Schibli R, Schubiger P A. Eur J Nucl Med, 2002, 29: 1529.
[9] Jiang Y, Liu B L. Chinese Science Bulletin, 2001, 46: 727-730.